Delivery Order SPE2DB20D7066-SPE2DB25FC4TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,029.32 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count) on August 21, 2025, with a completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,630.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 18, 2025, with completion targeted for August 19, 2025. This non-set-aside contract was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $3,852.25 under a firm fixed-price contract structure. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded delivery order has a ceiling value of $3,822.24 and is structured as a firm fixed price contract with an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,486.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (quantity 30) on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.98 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,121.12 to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Telmisartan is an antihypertensive medication commonly used in military and...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4TZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,254.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. This delivery order for Telmisartan, an antihypertensive medication commonly used in military medical supply chains, exemplifies the routine pharmaceutical procurement conducted through this primary vendor contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/16/25 |